Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:stavudine
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AF04
|
| gptkbp:CASNumber |
3056-17-5
|
| gptkbp:chemicalFormula |
C10H12N2O4
|
| gptkbp:contraindication |
gptkb:liver_disease
pregnancy |
| gptkbp:discontinued |
2017
|
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:eliminationHalfLife |
1 hour
|
| gptkbp:form |
capsule
oral solution |
| https://www.w3.org/2000/01/rdf-schema#label |
Zerit
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:marketedAs |
1994
|
| gptkbp:MedlinePlusID |
a601066
|
| gptkbp:MeSH_ID |
D019821
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
pancreatitis
peripheral neuropathy lactic acidosis |
| gptkbp:UNII |
X4HES1O11F
|
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:stavudine
gptkb:Roche |
| gptkbp:bfsLayer |
6
|